Explore the Global Clinical GenAI Safety Monitoring Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Clinical GenAI Safety Monitoring Market

Key Insight

Future Market Insights opines that the clinical GenAI safety monitoring market was valued at USD 450 million in 2025. Demand is expected to grow to USD 527 million in 2026 and USD 2,100 million by 2036. Hallucination and clinical risk monitoring are expected to lead with 29% share in 2026, and hospitals and IDNs are estimated to lead the care setting segment with 46% in 2026.

March 07, 2026

Anurag Sharma

250 Pages

Cite this Report

Clinical GenAI Safety Monitoring Market

https://www.futuremarketinsights.com/reports/clinical-genai-safety-monitoring-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Abridge
Arize AI
Arthur AI
Credo AI
Datadog
Fiddler AI
Nabla
TruEra
ValidMind
WhyLabs

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Clinical GenAI Safety Monitoring Market

Key Players

Similar Industry Reports